rediff.com

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  

Rediff News  All News 

Dcgi Rsquo

Rediff.com  »  News  »   Dcgi Rsquo

  News for Dcgi Rsquo

  • Business

After US, India to probe Ranbaxy's documents

After US, India to probe Ranbaxy’s documents SUSHMI DEY New Delhi, 22 May Health ministry tells DCGI to examine past dossiers, drug applications In what could be the beginning of fresh......

Why is Novartis likely to lose Tiamulin drug licence?

Swiss drug maker Novartis is likely to face legal action for allegedly faking documents to seek registration of its veterinary product Tiamulin Hydrogen Fumarate (80 per cent granules) in India.......

Ranbaxy whistle-blower to talk on quality of Made-in-India drugs

The concerns surrounding drug manufacturing practices in India appear to have reached foreign shores, beyond the international regulators’ domain.  Ranbaxy whistle-blower Dinesh Thakur,......

Keep us in loop before any FDA swoop, India tells US

Inspections only in domestic authorities’ presence, visiting US drug regulator told Taking a tough stand on the ongoing regulatory issues faced by the domestic pharmaceutical industry because......

After ban on drug facilities, US regulator comes calling

Margaret A Hamburg, the first commissioner of the US Food and Drug Administration (US FDA) to visit India officially, will meet heads of major domestic pharma companies such as Ranbaxy, Wockhardt,......
  Web results for Dcgi Rsquo
Why is Novartis likely to lose Tiamulin drug licence?

Swiss drug maker Novartis is likely to face legal action for allegedly faking documents to seek registration of its veterinary product Tiamulin... ...

http://www.rediff.com/money/report/why-is-novartis-likely-to-lose-tiamulin-drug-licence/20140319.htm
Keep us in loop before any FDA swoop, India tells US

Inspections only in domestic authorities’ presence, visiting US drug regulator told Taking a tough stand on the ongoing regulatory issues... ...

http://www.rediff.com/money/report/keep-us-in-loop-before-any-fda-swoop-india-tells-us/20140211.htm
Biocon contests Roche claims on cancer drug

Biocon has lashed out at Roche a day after the Swiss company secured an order from the Delhi High Court barring the Indian company from marketing... ...

http://www.rediff.com/money/report/biocon-contests-roche-claims-on-cancer-drug/20140208.htm
US FDA's action triggers internal conflict at Ranbaxy plant

The latest action by the US drug regulator against Ranbaxy’s Toansa factory is building up into an employer versus employee war.  While the... ...

http://www.rediff.com/money/report/us-fdas-action-triggers-internal-conflict-at-ranbaxy-plant/20140201.htm
Drug regulator lets pharma firms fix own penalty

Pharmaceutical companies could enjoy a leeway while pricing their products, with the drug regulator facing a resource crunch in its attempt to... ...

http://www.rediff.com/money/report/drug-regulator-lets-pharma-firms-fix-own-penalty/20140120.htm

Related Tags


  1. gujarat
  2. bjp
  3. india
  4. lok sabha
  5. supreme court
  6. upa
  7. bharatiya janata party
  8. congress
  9. new delhi
  10. united progressive alliance
  11. ahmedabad
  12. sonia gandhi
  13. nda
  14. rahul gandhi
  15. rajnath singh
  16. nitin gadkari
  17. delhi
  18. manmohan singh
  19. bihar
  20. national democratic alliance
  21. jd-u
  22. nitish kumar
  23. rashtriya swayamsevak sangh
  24. uttar pradesh
  25. photo
  26. advani
  27. central bureau of investigation
  28. rss
  29. janata dal-united
  30. ips

Top Coverage News


Why I love India - Independence Day Special 2013

The Rediff Independence Day Special 2013.

The Programmer Who Came In From The Cold

Whether history will remember Edward Snowden as a traitor to his country or as a champion for...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z